Cellectar Biosciences Inc (CLRB)

[MiamiGent]

CLRB In @ $3.19 +0.48 (+17.66%)

Not a lot of pick'ns this morning

https://stockcharts.com/h-sc/ui?s=CLRB

Volume 12,789,701
10/90-day avg. vol. 1M / 678K

Day range $2.92 - $3.36
52-week range $1.30 - $3.36

Cellectar Biosciences Announces Topline Data Achieving Primary Endpoint in Pivotal Clinical Study of Iopofosine I 131 in Waldenstrom's Macroglobulinemia
BENZINGA 6:32 AM ET Jan-08-2024

Cellectar Biosciences, Inc. (CLRB.NaE) , a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced data from its CLOVER WaM pivotal study, evaluating iopofosine I 131, a potential first-in-class, targeted radiotherapy candidate for the treatment of relapsed/refractory Waldenstrom's macroglobulinemia (WM) patients that have received at least two prior lines of therapy, including Bruton tyrosine kinase inhibitors (BTKi). CLOVER WaM is the largest study to date in relapsed or refractory WM patients post-BTKi therapy and represents the most refractory population ever tested in clinical studies based upon a review of published literature.